Logo Image
News|Articles|October 24, 2024

Tyrvaya® (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease.

Sponsored Content: Overview of dry eye disease pathophysiology and proper administration technique for the Tryvaya nasal spray. Tyrvaya is a registered trademark of Oyster Point Pharma, Inc., a Viatris Company.

Indication
Tyrvaya® (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.

Important Safety Information
The most common adverse reaction reported is 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation.

Please click here for full Prescribing Information.

Related Content

Latest CME

Payment for Pharmacist Services: 2025 Update
Online Article

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View more
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
On-Demand Webinar

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

1.0 Credit / Immunology, Rare Diseases

View more
The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care
On-Demand Webinar

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

1.0 Credit / Oncology

View more
Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment
On-Demand Webinar

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

1.0 Credit / Nephrology

View more
Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes
On-Demand Webinar

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

1.75 Credit / Hematologic Cancer, Hematology, Oncology

View more
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape
On-Demand Webinar

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

View more
Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes
Online Article

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

View more
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
On-Demand Webinar

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

View more
Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists
On-Demand Webinar

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

1.25 Credits / Hematologic Cancer, Oncology

View more
Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions
On-Demand Webinar

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

1.0 Credits / Hematologic Cancer, Oncology, Hematology

View more
Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma
On-Demand Webinar

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

0.5 Credit / Hematologic Cancer, Hematology, Oncology

View more
Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies
On-Demand Webinar

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

1.25 Credit / Hematologic Cancer, Hematology, Oncology

View more
Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies
On-Demand Webinar

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

0.5 Credit / Hematologic Cancer, Hematology, Oncology

View more
From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies
On-Demand Webinar

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

1.25 Credit / Hematologic Cancer, Hematology, Oncology

View more
The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)
Online Article

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

1.0 Credit / General Pharmacy

View more
The Pharmacist's Role in Palliative and End of Life Symptom Management
Online Article

The Pharmacist's Role in Palliative and End of Life Symptom Management

1.0 Credit / General Pharmacy

View more
Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)
On-Demand Webinar

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

1.5 Credit / Immunization, Infectious Disease

View more
Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients
On-Demand Webinar

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

1.5 Credit / Immunization, Infectious Disease

View more